Article Text

Download PDFPDF
Fertility-Sparing Therapy in Young Women With Endometrial Cancer: 2010 Update
  1. Serkan Erkanli, MD and
  2. Ali Ayhan, MD
  1. Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Baskent University Medical Faculty, Ankara, Turkey.
  1. Address correspondence and reprint requests to Serkan Erkanli, MD, Baskent Universitesi Seyhan Hastanesi, Kadın Hast ve Dogum AD, Baraj Yolu sok, Adana, Turkey. E-mail: serkanli{at}


Endometrial cancer (EC) in young and especially null gravid women is a challenging problem with increasing frequency due to both detailed investigations for infertile couples seeking treatment in in vitro fertilization centers and women delaying their plans for pregnancy. Considering very low number of such cases in the literature, fertility-sparing therapy for EC in young women is not standard, although it is widely used. In this review we searched the relevant literature, reviewed selection criteria, therapeutic options, response rates to therapy, special challenges, reproductive outcomes, and follow-up strategies for young women diagnosed with EC.

  • Fertility-sparing therapy
  • Endometrial cancer
  • Young women
  • Progesterone therapy
  • Endometrial carcinoma

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.